Informing participants in clinical trials with ex vivo human tissue-engineered products: What to tell and how to tell it?

Journal of Tissue Engineering and Regenerative Medicine

Volumn 2, Issue 4, 2008, Pages 236-241

  Trommelmans, Leen ^a   Selling, Joseph ^b   Dierickx, Kris ^a  

^a Centre for Biomedical Ethics and Law   (Belgium)

^b Faculty of Theology and Religious Studies   (Belgium)

Author keywords

Clinical trials; Ethics; Informed consent; Regenerative medicine; Tissue engineering

Indexed keywords

CELL ENGINEERING; DECISION MAKING; MOLECULAR BIOLOGY; TISSUE; TISSUE ENGINEERING;

AUTONOMOUS DECISION; CLINICAL TRIAL; EX-VIVO; HUMAN TISSUES; INFORMED CONSENT; PROSPECTIVES; REGENERATIVE MEDICINE; TISSUE ENGINEERED PRODUCTS; TISSUES ENGINEERINGS; VIVO TISSUE;

REGENERATIVE MEDICINE;

ADULT STEM CELL; AUDIOVISUAL EQUIPMENT; CELL DIFFERENTIATION; CELL TYPE; CULTURE MEDIUM; DECISION MAKING; EMBRYONIC STEM CELL; HEALTH CARE PERSONNEL; HUMAN; INFORMATION PROCESSING; INFORMED CONSENT; MEDICAL INSTRUMENTATION; PATIENT CARE; PERSONAL EXPERIENCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REGENERATION; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; TISSUE ENGINEERING; ARTICLE; CLINICAL TRIAL; ETHICS; PATIENT EDUCATION; PERSONAL AUTONOMY; RISK FACTOR; STANDARD;

CLINICAL TRIALS AS TOPIC; HUMANS; INFORMED CONSENT; PATIENT EDUCATION AS TOPIC; PERSONAL AUTONOMY; RISK FACTORS; TISSUE ENGINEERING;

EID: 52449089653     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.82     Document Type: Review

References (53)

1. Nuremberg Military Trial. The Nuremberg Code. J Am Med Assoc 1996; 276: 1691.
2. Anon. Uninformed consent? Nat Med 2007; 13: 999.
3. Andrews L, Nelkin D. Body Bazaar. The Market for Human Tissue in the Biotechnology Age. Crown Publishers: New York, 2001.
4. Appelbaum PS, Roth LH, Lidz CW, et al. False hopes and best data: consent to research and the therapeutic misconception. Hastings Cent Rep 1987; 17: 20-24.
5. Atala A, Bauer S, Soker S, et al. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 2006; 367: 1241-1246.
6. Barrett R. Quality of informed consent: measuring understanding among participants in oncology clinical trials. Oncol Nurs Forum 2005; 32: 751-755.
7. Beauchamp T, Childress J. Principles of Biomedical Ethics, vol 5. Oxford University Press: Oxford, 2001.
8. Bok S. Shading the truth in seeking informed consent for research purposes. Kennedy Inst Ethics J 1995; 5: 1-17.
9. Cancedda R, Giannoni P, Mastrogiacomo M. A tissue engineering approach to bone repair in large animal models and in clinical practice. Biomaterials 2007; 28: 4240-4250.
10. Comité Consultatif National d'Ethique (France) and Nationaler Ethikrat (Germany). Opinion No 77; ethical problems raised by the collected biological material and associated information data. 'Biobanks', 'Biolibraries', 2003; http://www.ccneethique. fr/english/start.htm.
11. Council for International Organizations of Medical Sciences (CIOMS). International Ethical Guidelines for Biomedical Research Involving Human Subjects. CIOMS: Geneva, Switzerland, 1993.
12. Council of Europe. Additional Protocol to the Convention on Human Rights and Biomedicine, concerning Biomedical Research, 2005; http://conventions.coe. int/treaty/en/treaties/html/195. htm (accessed 24 January 2008).
13. Daar AS, Greenwood HL. A proposed definition of regenerative medicine. J Tissue Eng Regen Med 2007; 1: 179-184.
14. Daar AS. Xenotransplantation and religion: the major monotheist religions. Xeno 1994; 2: 61.
15. Dickenson D. Property in the Body: Feminist Perspectives. Law, Medicine and Ethics Series. Cambridge University Press: Cambridge, MA, 2007.
16. Eggers C, Obliers R, Koerfer A, et al. A multimedia tool for the informed consent of patients prior to gastric banding. Obesity (Silver Spring) 2007; 15: 2866-2873.
17. El-Wakeel H, Taylor GJ, Tate JJ. What do patients really want to know in an informed consent procedure? A questionnaire-based survey of patients in the Bath area, UK. J Med Ethics 2006; 32: 612-616.
18. EMEA. ICH Topic E6 (R1). Guidelines for Good Clinical Practice. Step 5. Note for guidance on good clinical practice, 2002; CPMP/ICH/135/95: http://www.emea.europa.eu/pdfs/human/ich/013595en.pdf (accessed 24 January 2008).
19. Enoch S, Shaaban H, Dunn KW. Informed consent should be obtained from patients to use products (skin substitutes) and dressings containing biological material. J Med Ethics 2005; 31: 2-6.
20. EurActiv.com. MEPs drop ethical debate in gene-therapy vote, 2007; http://www.euractiv.com/en/health/meps-dropethical-debate-gene-therapy-vote/ article-161342 (accessed 24 January 2008).
21. European Commission. Enterprise and Industry Directorate-General. Consumer Goods. Pharmaceuticals. Detailed guidance on the application format and documentation to be submitted in an application for an Ethics Committee opinion on the clinical trial on medicinal products for human use. Revision 1, 2006; ENTR/CT2: http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/vol-10/12 ec guideline 20060216.pdf (accessed 24 January 2008).
22. European Commission. Health and Consumer Protection Directorate-General. Opinion on the state of the art concerning tissue engineering. Adopted by the Scientific Committee on Medicinal Products and Medical Devices on 1 October 2001; Doc. SANCO/SCMPMD/2001/0006Final: http://europa.eu.int/comm/food/fs/sc/ scmp/out37 en.pdf (accessed 24 January 2008).
23. European Parliament and the Council. Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use, 2001; L121-34-44: http://eurlex. europa.eu/smartapi/cgi/sga doc?smartapi!celexapi!prod! CELEXnumdoc&numdoc= 32001L0020&model=guichett&lg=en (accessed 24 January 2008).
24. European Parliament. European Parliament Legislative Resolution of 25 April 2007 on the Proposal for a Regulation of the European Parliament and of the Council on Advanced Therapy Medicinal Products and Amending Directive 2001/83/EC and Regulation (EC) No 726/2004 (COM(2005)0567 - C6-0401/2005-2005/ 0227(COD)) (Codecision procedure; first reading), 2007; http://www.europarl. europa. eu/sides/getDoc.do?pubRef=-//EP//TEXT+TA+P6-TA-2007-0144+0+DOC+XML+V0// EN (accessed 24 January 2008).
25. Flory J, Emanuel E. Interventions to improve research participants' understanding in informed consent for research: a systematic review. J Am Med Assoc 2004; 292: 1593-1601.
26. Giannoni P, Cancedda R. Articular chondrocyte culturing for cell-based cartilage repair: needs and perspectives. Cells Tissues Organs 2006; 184: 1-15.
27. Hermann M. Three-dimensional computer animation - a new paradigm for supporting patient education before surgery. Acceptance and assessment of patients based on a prospective randomized study - picture versus text. Chirurg 2002; 73: 500-507.
28. Hutchison C, Cowan C, McMahon T, et al. A randomised controlled study of an audiovisual patient information intervention on informed consent and recruitment to cancer cllinical trials. Br J Cancer 2007; 97: 705-711.
29. Iltis A. Lay concepts in informed consent to biomedical research; the capacity to understand and appreciate risk. Bioethics 2006; 20: 180-190.
30. Joffe S, Cook EF, Cleary PD, et al. Quality of informed consent in cancer clinical trials; a cross-sectional survey. Lancet 2001; 358: 1772-1777.
31. Kass NE, Sugarman J, Faden R, et al. Trust, the fragile foundation of contemporary biomedical research. Hastings Cent Rep 1996; 26: 25-29.
32. Kimmelman J, Palmour N. Therapeutic optimism in the consent forms of Phase 1 gene transfer trials: an empirical analysis. J Med Ethics 2005; 31: 209-214.
33. Kuijer R, Jansen EJ, Emans PJ, et al. Assessing infection risk in implanted tissue-engineered devices. Biomaterials 2007; 28: 5148-5154.
34. Kusec S, Oreskovic S, Skegro M, et al. Improving comprehension of informed consent. Patient Educ Couns 2006; 60: 294-300.
35. Landecker H. Culturing Life: How Cells Became Technologies. Harvard University Press: Cambridge, MA, 2007.
36. L'Heureux N, Dusserre N, Konig G, et al. Human tissue-engineered blood vessels for adult arterial revascularization. Nat Med 2006; 12: 361-365.
37. McGaughey I. Informed consent and knee arthroscopies; an evaluation of patient understanding and satisfaction. Knee 2004; 11: 237-242.
38. Morin K, Rakatansky H, Riddick FA Jr, et al. Managing conflicts of interest in the conduct of clinical trials. J Am Med Assoc 2002; 287: 78-84.
39. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report. US Government Printing Office: Washington, DC, 1979.
40. National Consultative Ethics Committee for Health and Life Sciences (CCNE). Opinion No. 93: commercialisation of human stem cells and other cell lines, 2007; http://www.ccneethique. fr/english/pdf/avis093.pdf.
41. National Patient Safety Agency, National research ethics service. Information sheets and consent forms guidance for researchers and reviewers, version 3.2, May 2007; http://www.nres.npsa.nhs.uk/rec-community/guidance/ #InformedConsent (accessed 24 January 2008).
42. Newton-Howes PA, Bedford ND, Dobbs BR, et al. Informed consent: what do patients want to know? N Z. Med J 1998; 111: 340-342.
43. Panici PB, Bellati F, Boni T, et al. Vaginoplasty using autologous in vitro cultured vaginal tissue in a patient with Mayer-von Rokitansky-Kuster-Hauser syndrome. Hum Reprod 2007; 22: 2025-2028.
44. Rosner F. Pig organs for transplantation into humans; a Jewish view. Mt Sinai J Med 1999; 66: 314-319.
45. Rossi M, McClellan R, Chou L, et al. Informed consent for ankle fracture surgery; patient comprehension of verbal and videotaped information. Foot Ankle Int 2004; 25: 756-762.
46. Rossi MJ, Guttmann D, MacLennan MJ, et al. Video informed consent improves knee arthroscopy patient comprehension. Arthroscopy 2005; 21: 739-743.
47. Sievert KD, Amend B, Stenzl A. tissue engineering for the lower urinary tract: a review of a state of the art approach. Eur Urol 2007; 52: 1580-1589.
48. Sleight P. Where are clinical trials going? Society and clinical trials. J Intern Med 2004; 255: 151-158.
49. Stead M, Eadie D, Gordon D, et al. 'Hello, hello - it's English I speak!', a qualitative exploration of patients' understanding of the science of clinical trials. J Med Ethics 2005; 31: 664-669.
50. Strevel EL, Newman C, Pond GR, et al. The impact of an educational DVD on cancer patients considering participation in a Phase I clinical trial. Support Care Cancer 2007; 15: 829-840.
51. Waldby C, Mitchell R. Tissue Economies. Blood, Organs and Cell Lines in Late Capitalism. Duke University Press: Durham (USA) and London, 2006.
52. Wendler D. Can we ensure that all research subjects give valid consent? Arch Intern Med 2004; 164: 2201-2204.
53. World Medical Association. Declaration of Helsinki. J Am Med Asoc 1997; 277: 925-926.